Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: CML Highlights of EHA 2025 - Clinical overview

Andreas hochhaus

Expert:

Professor Andreas Hochhaus
Director of the Department of Hematology and Medical Oncology
Jena University Hospital (Germany)

iCMLf Conversation: CML Highlights of EHA 2025 - Biological overview

Professor Tomasz Stokłosa

Expert:

Professor Tomasz Stokłosa
Head, Department of Tumor Biology and Genetics / Laboratory of Molecular Genetics and Cytogenetics, University Clinical Center
Medical University of Warsaw (Poland) 

iCMLf Conversation: CML Highlights of ASH 2024 - Biological overview

susan branford

Expert:

Professor Susan Branford
Head, Leukemia Unit, Genetics and Molecular Pathology, SA Pathology, Adelaide (Australia)

iCMLf Conversation: CML Highlights of ASH 2024 - Clinical overview

Hughes.Tim Precision Medicine 3 PURE

Expert:

Professor Timothy Hughes
Clinical Director, Precision Cancer Medicine Theme at SAHMRI /
Cancer Professor University of Adelaide /
Consultant Haematologist at the Royal Adelaide Hospital (Australia)

iCMLf Conversation: Highlights of ESH-iCMLf 25th Annual John Goldman Conference on CML- Biological overview incl. Q&A Session

Daniela Krause

Expert:

Professor Daniela Krause
Director of the Institute of Transfusion Medicine at the University of Mainz  (Germany)